MSB 3.21% $1.13 mesoblast limited

Hi @Caccs1yes, but only if the FDA determines that the Complete...

  1. 1,480 Posts.
    lightbulb Created with Sketch. 3255
    Hi @Caccs1

    yes, but only if the FDA determines that the Complete Response resubmission to the FDA's Complete Response letter is not incomplete.

    I know, it's both tautological & paradoxical. Bureaucracy inaction. Sorry, should have been "in action" (nah, just kidding, it's inaction).

    Cheers
    GLTA(LT)H
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.